These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. The flexible FIGO classification concept for underlying causes of abnormal uterine bleeding. Munro MG; Critchley HO; Fraser IS Semin Reprod Med; 2011 Sep; 29(5):391-9. PubMed ID: 22068978 [TBL] [Abstract][Full Text] [Related]
44. Historical Perspectives and Evolution of Menstrual Terminology. Chodankar RR; Munro MG; Critchley HOD Front Reprod Health; 2022; 4():820029. PubMed ID: 36303670 [TBL] [Abstract][Full Text] [Related]
45. Practical aspects of the two FIGO systems for management of abnormal uterine bleeding in the reproductive years. Munro MG Best Pract Res Clin Obstet Gynaecol; 2017 Apr; 40():3-22. PubMed ID: 27836285 [TBL] [Abstract][Full Text] [Related]
46. Endometrial cancer and hyperplasia rate in women before menopause with abnormal uterine bleeding undergoing endometrial sampling. Gawron I; Łoboda M; Babczyk D; Ludwin I; Basta P; Pityński K; Ludwin A Przegl Lek; 2017; 74(4):139-43.. PubMed ID: 29696944 [TBL] [Abstract][Full Text] [Related]
47. Efficacy of ormeloxifene versus oral contraceptive in the management of abnormal uterine bleeding due to uterine leiomyoma. Kriplani A; Srivastava A; Kulshrestha V; Kachhawa G; Agarwal N; Bhatla N; Hari S J Obstet Gynaecol Res; 2016 Dec; 42(12):1744-1752. PubMed ID: 27647770 [TBL] [Abstract][Full Text] [Related]
49. Recent advances in managing and understanding menstrual disorders. Bahamondes L; Ali M F1000Prime Rep; 2015; 7():33. PubMed ID: 25926984 [TBL] [Abstract][Full Text] [Related]
50. Abnormal uterine bleeding: advantages of formal classification to patients, clinicians and researchers. Madhra M; Fraser IS; Munro MG; Critchley HO Acta Obstet Gynecol Scand; 2014 Jul; 93(7):619-25. PubMed ID: 24702613 [TBL] [Abstract][Full Text] [Related]
51. Investigation and management of abnormal uterine bleeding in reproductive-aged women: a descriptive review of national and international recommendations. Tsakiridis I; Giouleka S; Koutsouki G; Kostakis N; Kalogiannidis I; Kourtis A; Athanasiadis A; Goulis DG; Dagklis T Eur J Contracept Reprod Health Care; 2022 Dec; 27(6):504-517. PubMed ID: 36053280 [TBL] [Abstract][Full Text] [Related]
52. Histopathological correlation of adenomyosis and leiomyoma in hysterectomy specimens as the cause of abnormal uterine bleeding in women in different age groups in the Kumaon region: A retroprospective study. Rizvi G; Pandey H; Pant H; Chufal SS; Pant P J Midlife Health; 2013 Jan; 4(1):27-30. PubMed ID: 23833530 [TBL] [Abstract][Full Text] [Related]
53. Abnormal Uterine Bleeding: Current Classification and Clinical Management. Bacon JL Obstet Gynecol Clin North Am; 2017 Jun; 44(2):179-193. PubMed ID: 28499529 [TBL] [Abstract][Full Text] [Related]
54. Classification and the diagnostics of abnormal uterine bleeding in nongravid women of reproductive age: The PALM-COEIN classification system adopted by the International Federation of Gynecology and Obstetrics. Spremović-Rađenović S; Stefanović A; Kadija S; Jeremić K; Sparić R Vojnosanit Pregl; 2016 Dec; 73(12):1154-9. PubMed ID: 29341573 [No Abstract] [Full Text] [Related]
55. The assessment of the relationship between the vascularity of FIGO Type 4-7 leiomyomas and abnormal uterine bleeding. Gursoy AY; Cakmak D; Akgul G; Kiseli M; Umudum H; Pabuccu R; Caglar GS J Obstet Gynaecol; 2022 Jan; 42(1):153-157. PubMed ID: 33938365 [TBL] [Abstract][Full Text] [Related]
56. Update on the management of abnormal uterine bleeding. Levy-Zauberman Y; Pourcelot AG; Capmas P; Fernandez H J Gynecol Obstet Hum Reprod; 2017 Oct; 46(8):613-622. PubMed ID: 28716637 [TBL] [Abstract][Full Text] [Related]